Guizhou Yibai Pharmaceutical Co., Ltd.

XSSC:600594 Stock Report

Market Cap: CN¥3.0b

Guizhou Yibai Pharmaceutical Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Ya Qi Dou

Chief executive officer

CN¥2.3m

Total compensation

CEO salary percentagen/a
CEO tenure13.5yrs
CEO ownership0.03%
Management average tenureno data
Board average tenure5.1yrs

Recent management updates

Recent updates

CEO

Ya Qi Dou (40 yo)

13.5yrs

Tenure

CN¥2,266,500

Compensation

Ms. Ya Qi Dou has been a General Manager of Guizhou Yibai Pharmaceutical Co Ltd. since May 14, 2021 and was its Deputy General Manager since April 25, 2011 until May 14, 2021 and has been its Vice Chairman...

Board Members

NamePositionTenureCompensationOwnership
Ya Qi Dou
GM & Vice Chairman16.4yrsCN¥2.27m0.033%
CN¥ 1.0m
Hong Ping Lang
President & Vice-Chairman21.8yrsCN¥1.68m1.0%
CN¥ 30.1m
Zhiwei Wang
Executive Deputy GM & Director13.7yrsCN¥2.27m0.23%
CN¥ 6.9m
Qiling Dou
Chairwoman29.3yrsCN¥2.48m23.42%
CN¥ 706.6m
Wu Zhang
Independent Director5.1yrsCN¥30.00kno data
Weijun Gu
Independent Director5.1yrsCN¥30.00kno data
Jiangtao Zhai
Director5.1yrsno datano data
Tao Jiang
Chairman of the Supervisory Board3.4yrsno data0.0019%
CN¥ 57.0k
Jian Pu
Supervisor3.4yrsno data0.00018%
CN¥ 5.4k

5.1yrs

Average Tenure

54yo

Average Age

Experienced Board: 600594's board of directors are considered experienced (5.1 years average tenure).